Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: crysball who wrote (1119)	8/6/1998 8:45:00 PM
From: ROBERT M. SILVER	Read Replies (1) \| Respond to of 1491

Dear Neil, I talked to officers of the company about the European expansion of licensed products Lotemax and Alrex. Since the information I received was a little different from that posted, I will attempt to clarify for the purpose of being accurate. As to third quarter 1998, the company hopes to apply or file an application for approval of Lotemax in Great Britain, and Alrex in the Netherlands. Bob Cook expressed the opinion that it would take six to nine months to get approvals from these countries. Gad Riesenfeld stated that it was not possible to predict when these approvals might be issued by either country. I think the most optimistic view is for approval in the two countries by Summer, 1999. Then it would depend upon Bausch and Lomb to launch the product. Their track record on Lotemax and Alrex required about 90 days to get on tract. Now we are in fall 1999. If there are no other delays (Murphy's Law) it might be reasonable to expect earnings in the 4th quarter 1999. An official also mentioned they would like to file an application in Germany as well. (This was not on the conference call) There could be no reasonably commercial reason to go into Russia. The average Russian salary is about $75 a month. And that is for skilled labor. The company wants to sell the product at least $15 a dosage (bottle or what have you) The Pharmos official I discussed this with said it is not productive to be in any socialized country (France, Spain and Italy) were mentioned, where the company could not get a fair return on their product. They may not say that for public consumption, for fear of offending some, but that is the fact. I would think that after Germany, Japan might be a productive location to work on as would Australia, and New Zealand. Regards, Robert